home All News open_in_new Full Article

Estados Unidos aprueba la píldora Wegovy de Novo Nordisk contra la obesidad

Estados Unidos aprueba la semaglutida oral Wegovy de Novo Nordisk como primera píldora GLP-1 oral para el control de peso y la obesidad. La pastilla alcanza porcentajes de pérdida de peso corporal del 16%. Leer


today 32 h. ago attach_file Politics

attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1382153932
Add Watch Country

arrow_drop_down